abrdn Life Sciences Investors director buys 7,923 HQL shares

abrdn Life Sciences Investors reported that one of its directors acquired 7,923 shares of its common stock on 12/16/2025 at a price of $16.8818 per share.

Accepted by SEC EDGAR 12/18/2025 - 11:16 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

abrdn Life Sciences Investors reported that one of its directors acquired 7,923 shares of its common stock on 12/16/2025 at a price of $16.8818 per share. Following this transaction, the director directly beneficially owned 7,923 shares of the company.

Insider Trade Summary

Net Buyer: 7,923 shares

Net Buy 1 txn

Insider Pittard Christian

Role Director

Bought 7,923 shs ($134K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	7,923	$16.8818	$134K

Holdings After Transaction: Common Stock — 7,923 shares (Direct)

Holdings Before and After: Common Stock, 0 to 7,923 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction involving abrdn Life Sciences Investors (HQL) shares was reported?

A director of abrdn Life Sciences Investors acquired 7,923 shares of the company’s common stock at a price of $16.8818 per share.

When did the HQL director’s share purchase take place?

The transaction date for the director’s acquisition of common stock was 12/16/2025.

What is the reporting person’s relationship to abrdn Life Sciences Investors (HQL)?

The reporting person is identified as a Director of abrdn Life Sciences Investors.

How many abrdn Life Sciences Investors (HQL) shares did the director own after the transaction?

After the reported transaction, the director beneficially owned 7,923 shares of common stock, held with direct ownership.

Was this HQL Form 4 filed for one or multiple reporting persons?

The document indicates that the Form was filed by one reporting person, not by a group.

What address is listed for the reporting person in the HQL Form 4?

The address listed is C/O abrdn, 1900 Market Street, Suite 200.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pittard Christian

(Last) (First) (Middle)

C/O ABRDN

1900 MARKET STREET, SUITE 200

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
abrdn Life Sciences Investors [ HQL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/16/2025		P		7,923	A	$16.8818	7,923	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Robert Stieger, by POA from Reporting Person	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.